MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Cogentix Medical Company Profile (NASDAQ:CGNT)

Consensus Ratings for Cogentix Medical (NASDAQ:CGNT) (?)
Ratings Breakdown: 1 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.15 (11.65% upside)

Analysts' Ratings History for Cogentix Medical (NASDAQ:CGNT)
Show:
DateFirmActionRatingPrice TargetActions
5/6/2016Roth CapitalDowngradeBuy -> Neutral$2.00 -> $1.15View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for Cogentix Medical (NASDAQ:CGNT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
5/5/2016        
3/3/2016Q4($0.07)($0.04)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q216($0.07)($0.09)$11.45 million$11.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q116($0.10)($0.14)$11.34 million$11.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/14/2015Q415($0.06)($0.15)$49.10 million$7.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/5/2015Q315($0.03)$4.92 million$4.51 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2014Q115($0.04)$3.65 million$3.75 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2014Q3 14($0.03)$4.00 million$4.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2013Q1 2014($0.05)$34.00 million$3.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2012Q213($0.06)($0.07)$3.85 million$3.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Cogentix Medical (NASDAQ:CGNT)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.05)($0.03)($0.04)
Q2 20161($0.03)($0.03)($0.03)
Q3 20161($0.03)($0.03)($0.03)
Q4 20161($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)
Dividend History for Cogentix Medical (NASDAQ:CGNT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Cogentix Medical (NASDAQ:CGNT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/10/2016Lewis C PellDirectorBuy13,291$0.95$12,626.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016Lewis C PellDirectorBuy894$0.75$670.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2016Lewis C PellDirectorBuy500,000$0.79$395,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2015Kevin H RocheDirectorBuy10,000$1.68$16,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2015Kevin H RocheDirectorBuy10,000$1.60$16,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2015Lewis C PellDirectorBuy20,000$0.51$10,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2015Lewis C PellDirectorBuy10,000$0.48$4,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2015Lewis C PellDirectorBuy30,000$0.45$13,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2015Lewis C PellDirectorBuy20,000$0.47$9,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2015Lewis C PellDirectorBuy35,000$0.46$16,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/23/2014Lewis C PellDirectorBuy80,000$0.85$68,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2014Lewis C PellDirectorBuy40,000$0.86$34,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/23/2014Lewis C PellDirectorBuy5,000$0.99$4,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2014Lewis C PellDirectorBuy3,900$1.00$3,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2014Lewis C PellDirectorBuy5,000$1.02$5,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2014Lewis C PellDirectorBuy5,000$1.07$5,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2014Lewis C PellDirectorBuy23,300$1.04$24,232.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Lewis C PellDirectorBuy30,000$1.04$31,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014Lewis C PellDirectorBuy30,000$0.98$29,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Lewis C PellDirectorBuy10,000$0.92$9,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014Lewis C PellDirectorBuy30,000$0.93$27,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014Lewis C PellDirectorBuy22,900$0.98$22,442.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014Lewis C PellDirectorBuy43,420$0.91$39,512.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2014Lewis C PellDirectorBuy27,500$0.95$26,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2014Lewis C PellDirectorBuy10,000$1.13$11,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2014Lewis C PellDirectorBuy5,000$1.09$5,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2014Lewis C PellDirectorBuy14,197$1.02$14,480.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2013Lewis C PellDirectorBuy6,296$0.91$5,729.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/15/2013Lewis C PellDirectorBuy20,000$0.90$18,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013Lewis C PellDirectorBuy16,000$0.91$14,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2013Lewis C PellDirectorBuy5,000$0.92$4,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2013Lewis C PellDirectorBuy5,000$0.92$4,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013Lewis C PellDirectorBuy4,564$0.95$4,335.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/6/2013Lewis C PellDirectorBuy5,000$0.97$4,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Lewis C PellDirectorBuy11,432$0.97$11,089.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/29/2013Lewis C PellDirectorBuy1,100$0.98$1,078.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2013Lewis C PellDirectorBuy11,596$0.97$11,248.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013Lewis C PellDirectorBuy14,965$0.97$14,516.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013Lewis C PellDirectorBuy25,025$0.94$23,523.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013Lewis C PellDirectorBuy15,000$0.92$13,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/28/2013Lewis C PellDirectorBuy28,400$1.00$28,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/27/2013Lewis C PellDirectorBuy45,048$0.99$44,597.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2013Lewis C PellDirectorBuy30,000$1.14$34,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2013Lewis C PellDirectorBuy45,000$1.10$49,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2013Lewis C PellDirectorBuy60,000$1.09$65,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2013Lewis C PellDirectorBuy20,000$1.06$21,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2013Lewis C PellDirectorBuy66,266$1.01$66,928.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/21/2013Lewis C PellDirectorBuy25,000$0.99$24,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2013Lewis C PellDirectorBuy5,000$0.99$4,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/7/2013Lewis C PellDirectorBuy9,000$0.99$8,910.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2013Lewis C PellDirectorBuy25,000$1.01$25,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/1/2013Lewis C PellDirectorBuy10,000$1.09$10,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/27/2012Lewis C PellDirectorBuy10,000$1.07$10,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2012Lewis C PellDirectorBuy21,600$1.10$23,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/13/2012Lewis C PellDirectorBuy18,961$1.10$20,857.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2012Lewis C PellDirectorBuy6,656$1.10$7,321.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2012Lewis C PellDirectorBuy8,360$1.10$9,196.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/30/2012Lewis C PellDirectorBuy45,748$1.10$50,322.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2012Lewis C PellDirectorBuy3,593$1.10$3,952.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/23/2012Lewis C PellDirectorBuy39,357$1.09$42,899.13View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2012Lewis C PellDirectorBuy57,050$1.08$61,614.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2012Lewis C PellDirectorBuy100,000$1.15$115,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2012Lewis C PellDirectorBuy24,852$1.17$29,076.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/6/2012Lewis C PellDirectorBuy10,000$1.37$13,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Cogentix Medical (NASDAQ:CGNT)
DateHeadline
06/22/16 03:06 PMCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers -
06/22/16 06:19 AMHealthcare Industry Leader Kenneth A. Samet Joins Cogentix Medical Board of Directors - [at noodls] - MINNEAPOLIS, June 22, 2016 /PRNewswire/ -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, ...
06/16/16 07:34 AMCogentix re-hires CFO who left five months ago
06/15/16 06:19 AMBrett Reynolds Rejoins Cogentix Medical As Chief Financial Officer - [at noodls] - MINNEAPOLIS, June 15, 2016 /PRNewswire/ -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, ...
06/15/16 06:06 AMCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh -
06/06/16 03:16 PMCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or S -
06/03/16 09:15 PMInsiders Roundup: Buy of Advance Auto Parts, Sale of Fitbit
06/03/16 03:15 PMInsiders Roundup: Buys of Advance Auto Parts, Sales of Fitbit
05/27/16 03:29 PMCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Prin -
05/26/16 01:17 PMHealthcare New Lows: Five Star Quality Care (NYSE:FVE), Cogentix Medical, Inc. (NASDAQ:CGNT), Consumer ... - KC Register - Healthcare New Lows: Five Star Quality Care (NYSE:FVE), Cogentix Medical, Inc. (NASDAQ:CGNT), Consumer ...KC RegisterCogentix Medical, Inc. (NASDAQ:CGNT) has entered into a settlement agreement which will be attached to a Form 8-K to be filed by Cogentix. Pursuant to the settlement agreement, Cogentix and its Board of Directors have agreed to support the proposals ...
05/26/16 01:17 PMCogentix CEO and two board members are out after shareholder battle - Cogentix Medical CEO Rob Kill and two board members are stepping down ... a former UnitedHealth Group Inc. executive. The leadership changes follow criticism of Kill from Lewis Pell, a large shareholder and founder of Orangeburg, N.Y.-based Vision-Sciences ...
05/26/16 01:17 PMCogentix accedes to proxy war, ousts CEO Kill - Cogentix Medical (NSDQ:CGNT) said today it entered into a settlement agreement ... EndoSheath is a sterile, disposable protective barrier designed to work with its flexible endoscopes. NN, Inc. Precision Engineered Products Group (PEP), a global ...
05/24/16 07:38 AM8:38 am Cogentix Medical announces settlement agreement in connection with proxy contest/related litigation and leadership changes; annual meeting to be held May 24 at 1pm ET -
05/24/16 07:35 AMCogentix Medical Announces Settlement Agreement in Connection with Proxy Contest and Related Litigation and Leadership Changes; Annual Meeting To Be Held May 24, 2016 at 12:00 P.M. Central Daylight Time - [PR Newswire] - MINNEAPOLIS, May 24, 2016 /PRNewswire/ -- Cogentix Medical, Inc. (CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, has entered into a settlement agreement which will be attached to a Form 8-K to be filed by Cogentix. Pursuant to the settlement agreement, Cogentix and its Board of Directors have agreed to support the proposals set forth in the definitive proxy statement filed by Lewis C. Pell in connection with the Annual Meeting, including the nomination for election at the Annual Meeting of Mr. Pell, Howard I. Zauberman and James D'Orta. Also pursuant to the settlement agreement, Robert C. Kill, Chairman of the Board and CEO, will resign as a director and officer of Cogentix and Darin Hammers, the current Chief Operating Officer, will be named as the interim CEO. Directors Kevin Roche and Ken Paulus will also depart Cogentix pursuant to the settlement agreement.
05/20/16 05:23 PMCogentix Medical Adjourns May 20, 2016 Annual Meeting in Response to Court Ruling; Adjourned Meeting Date Set for May 24, 2016 at 12:00 P.M. Central Daylight Time - [at noodls] - MINNEAPOLIS, May 20, 2016 /PRNewswire/ -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, ...
05/20/16 04:53 AMCogentix Medical Postpones May 20, 2016 Annual Meeting in Response to Court Ruling; New Meeting Date Set for May 24, 2016 at 12:00 P.M. Central Daylight Time - [at noodls] - MINNEAPOLIS, May 20, 2016 /PRNewswire/ -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, ...
05/09/16 03:28 PM/C O R R E C T I O N -- Cogentix Medical, Inc./ - [at noodls] - In the news release, The Nation's Two Leading Independent Proxy Advisory Firms Recommend Support Of Cogentix Medical Board Proposals, issued 09-May-2016 by Cogentix Medical, Inc. over PR Newswire, we are ...
05/09/16 10:38 AMThe Nation's Two Leading Independent Proxy Advisory Firms Recommend Support Of Cogentix Medical Board Proposals - [at noodls] - MINNEAPOLIS, May 9, 2016 /PRNewswire/ -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, today ...
05/06/16 02:57 PMEdited Transcript of CGNT earnings conference call or presentation 5-May-16 8:30pm GMT -
05/05/16 03:30 PMCogentix Medical Inc Earnings Call scheduled for 4:30 pm ET today -
05/05/16 03:21 PMCogentix Medical Achieves Second Consecutive Quarter of Cash Operating Profit; Reports 74% Revenue Growth for the Quarter Ended March 31, 2016 - [at noodls] - MINNEAPOLIS, May 5, 2016 /PRNewswire/ -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, today ...
03/05/16 01:54 PMCogentix Medical's (CGNT) CEO Rob Kill on Q4 2015 Results - Earnings Call Transcript - Seeking Alpha - Cogentix Medical's (CGNT) CEO Rob Kill on Q4 2015 Results - Earnings Call TranscriptSeeking AlphaWe are joined on today's call by Rob Kill, President and Chief Executive Officer; and Darin Hammers, Chief Operating Officer of Cogentix Medical. Management will provide some prepared remarks about the operating performance of the company, as well as ...Cogentix Medical Reports 104% Revenue Growth for the Quarter Ended December 31; Achieves Cash Operating Profit ...PR Newswire (press release)all 2 news articles »
03/05/16 01:54 PMSteady Stock: Cogentix Medical (NASDAQ:CGNT) - CWRU Observer - share market updates (press release)Steady Stock: Cogentix Medical (NASDAQ:CGNT)CWRU ObserverCogentix Medical Inc (NASDAQ:CGNT) is expected to report fourth quarter earnings after the close on Thursday, Mar 3, with a conference call scheduled for 4:30 pm EST. Cogentix Medical, Inc., a medical device company, designs, develops, manufactures, ...HC Stock Observant: Codexis Inc. (CDXS), Cogentix Medical Inc (CGNT), Aimmune Therapeutics Inc (AIMT)share market updates (press release)Cogentix Medical Incorporated (NASDAQ:CGNT) Sellers Increased By 12.67% Their ShortsClinton Financialall 3 news articles »
03/05/16 01:54 PMStock Review: Cogentix Medical Inc (CGNT) - share market updates (press release) - share market updates (press release)Stock Review: Cogentix Medical Inc (CGNT)share market updates (press release)Shares of Cogentix Medical Inc (NASDAQ:CGNT) ended Friday session in red amid volatile trading. The shares closed down -0.01 points or -0.88% at $1.13 with 35,737.00 shares getting traded. Post opening the session at $1.09, the shares hit an intraday ...
03/05/16 01:54 PMCogentix Medical's (CGNT) CEO Rob Kill on Q4 2015 Results - Earnings Call Transcript - Welcome to the Cogentix Medical Financial Results Call for the quarter and nine ... year ago” financial statements of operations includes only the former Uroplasty Inc. operations consistent with Uroplasty being deemed the accounting acquirer under ...
03/04/16 10:48 AMEdited Transcript of CGNT earnings conference call or presentation 3-Mar-16 9:30pm GMT -
03/03/16 03:10 PMCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and -
03/03/16 03:01 PMCogentix Medical Reports 104% Revenue Growth for the Quarter Ended December 31; Achieves Cash Operating Profit Milestone - [PR Newswire] - MINNEAPOLIS, March 3, 2016 /PRNewswire/ -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, ...
03/03/16 06:07 AMQ4 2016 Cogentix Medical Inc Earnings Release - After Market Close -
02/28/16 01:38 PMCogentix Medical Incorporated (NASDAQ:CGNT) Sellers Increased By 12.67% Their Shorts - Business Standard Tribune - Cogentix Medical Incorporated (NASDAQ:CGNT) Sellers Increased By 12.67% Their ShortsBusiness Standard TribuneThe short interest to Cogentix Medical Incorporated's float is 0.42%. The stock increased 11.00% or $0.12 on February 26, hitting $1.16. About 134,152 shares traded hands or 313.40% up from the average. Cogentix Medical Inc (NASDAQ:CGNT) has ...
02/27/16 01:43 PMHow Analysts Feel About Cogentix Medical Inc (NASDAQ:CGNT)? - Business Standard Tribune - How Analysts Feel About Cogentix Medical Inc (NASDAQ:CGNT)?Business Standard TribuneOut of 1 analysts covering Cogentix Medical (NASDAQ:CGNT), 1 rate it “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Cogentix Medical was the topic in 2 analyst reports since November 5, 2015 according to StockzIntelligence Inc. Roth ...
02/25/16 01:58 PMCogentix Medical to Report 2015 Year-End Results on March 3, 2016 - PR Newswire (press release) - Cogentix Medical to Report 2015 Year-End Results on March 3, 2016PR Newswire (press release)24, 2016 /PRNewswire/ -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, will release financial results for the quarter and fiscal year ...and more »
02/24/16 01:45 PMCogentix Medical to Report 2015 Year-End Results on March 3, 2016 - [PR Newswire] - MINNEAPOLIS, Feb. 24, 2016 /PRNewswire/ -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, ...
02/19/16 03:06 PMCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Shareholder Director Nominations, Other Events -
02/16/16 01:56 PMWere Analysts Bearish Cogentix Medical Inc (NASDAQ:CGNT) This Week? - Sonoran Weekly Review - Were Analysts Bearish Cogentix Medical Inc (NASDAQ:CGNT) This Week?Sonoran Weekly ReviewOut of 1 analysts covering Cogentix Medical (NASDAQ:CGNT), 2 rate it “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Cogentix Medical was the topic in 2 analyst reports since November 5, 2015 according to StockzIntelligence Inc. Below is ...
02/13/16 01:42 PMCogentix Medical Incorporated (NASDAQ:CGNT) Sellers Covered 5.66% of Their Shorts - fdanewsalert.com - Cogentix Medical Incorporated (NASDAQ:CGNT) Sellers Covered 5.66% of Their Shortsfdanewsalert.comThe short interest to Cogentix Medical Incorporated's float is 0.36%. The stock increased 5.88% or $0.06 on February 12, hitting $1.08. About 24,050 shares traded hands. Cogentix Medical Inc (NASDAQ:CGNT) has declined 36.20% since July 10, 2015 and is ...
02/10/16 07:17 PM13G Filing: Nantahala Capital Management and Cogentix Medical Inc (CGNT) -
02/10/16 01:25 PMCogentix Medical Incorporated (NASDAQ:CGNT) Sellers Covered 15.25% of Their Shorts - fdanewsalert.com - Cogentix Medical Incorporated (NASDAQ:CGNT) Sellers Covered 15.25% of Their Shortsfdanewsalert.comThe short interest to Cogentix Medical Incorporated's float is 0.38%. The stock is up 5.45% or $0.06 after the news, hitting $1.18 per share. About 3,509 shares traded hands. Cogentix Medical Inc (NASDAQ:CGNT) has declined 27.16% since July 2, 2015 and ...
02/03/16 03:06 PMCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or P -
02/02/16 05:00 AMCogentix Medical Announces Preliminary Resultsfor the Quarter Ended December 31 - [PR Newswire] - MINNEAPOLIS, Feb. 2, 2016 /PRNewswire/ -- Cogentix Medical, Inc. (CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, today announced preliminary unaudited revenue for the quarter ended December 31, 2015. Revenue is expected to be approximately $13.6 million, representing a 104% increase from the year ago period and an 18% increase from the pro forma combined revenue of Uroplasty and Vision-Sciences in the same period last year. "Our U.S. sales organization continued to execute during our most recent quarter as we generated solid growth from our Urgent PC and endoscopy product lines," said Rob Kill, President and CEO of Cogentix Medical.
01/30/16 01:34 PMCogentix Medical, Inc. (CGNT) - Cogentix Medical, Inc., a medical device company, designs, develops, manufactures, and markets products for the urology market and flexible endoscopy. The company offers Urgent PC neuromodulation system for the overactive bladder and associated symptoms of ...
12/11/15 07:06 AMCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regula -
12/08/15 12:17 PMCOGENTIX MEDICAL INC /DE/ Financials -
11/27/15 11:53 AMIs Dover Downs Gaming & Entertainment, Inc. (DDE) Going to Burn These Hedge Funds? -
11/24/15 11:47 AMHow Smart Money Is Trading Alphatec Holdings Inc (ATEC) -
11/12/15 04:37 PMCOGENTIX MEDICAL INC /DE/ Files SEC form 10-Q, Quarterly Report -
11/03/15 03:27 PMCogentix Medical Reports 83% Second Quarter Revenue Growth - [at noodls] - MINNEAPOLIS, Nov. 3, 2015 /PRNewswire/ -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, ...
11/03/15 06:07 AMQ2 2016 Cogentix Medical Inc Earnings Release - After Market Close -
10/21/15 06:00 AMCogentix Medical to Announce Second Quarter Fiscal 2016 Results on November 3, 2015 - [PR Newswire] - MINNEAPOLIS, Oct. 21, 2015 /PRNewswire/ -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, ...
10/02/15 09:52 AMCogentix Medical, Inc. Earnings Q1, 2016 -
About Cogentix Medical

Cogentix Medical logoCogentix Medical, Inc., formerly Vision-Sciences, Inc., is a medical device company. The Company designs, develops, manufactures and markets products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier, EndoSheath technology. The Company produces and markets Endoscopes, such as cystoscopes, ureteroscopes, laryngoscopes, otoscopes, sinuscopes, trans-nasal esophagoscopy (TNE) and bronchoscopes for medical use and borescopes for industrial use, and digital processing units (DPU). The Company offers Urgent PC Neuromodulation System, a nerve stimulation device that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder (OAB). It also offers Macroplastique, an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence. It markets additional bulking agents: PTQ for the treatment of fecal incontinence and the VOX for vocal cord augmentation.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CGNT
  • CUSIP:
Key Metrics:
  • Previous Close: $1.03
  • 50 Day Moving Average: $0.94
  • 200 Day Moving Average: $1.08
  • P/E Ratio: N/A
  • P/E Growth: 1.82
  • Market Cap: $26.73M
  • Current Quarter EPS Consensus Estimate: $0.04 EPS
Additional Links:
Cogentix Medical (NASDAQ:CGNT) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha